AzTrials
AzTrials

AsthmaEarly Phase 1NCT07036887

Effectiveness of 1st Rib Mobilization and Scalene Muscles Muscle Energy Technique Among Patients With Asthma

A Early Phase 1 study testing First Rib Mobilization + Respiratory Physiotherapy and Scalene Muscle Energy Technique (MET) + Respiratory Physiotherapy in people with Asthma, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This randomized controlled trial aims to evaluate the effectiveness of first rib mobilization and scalene muscle energy technique (MET) in improving respiratory function and reducing symptoms in patients with asthma. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Asthma
What is being tested?
First Rib Mobilization + Respiratory Physiotherapy and Scalene Muscle Energy Technique (MET) + Respiratory Physiotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
47 participants
Where
1 sitePakistan
Study dates
4 Mar 2025to 30 Sep 2025
Phase
Early Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Both male and female age range: 18-65 years.
  • Diagnosed with asthma according to the Global Initiative for Asthma criteria.
  • Presence of musculoskeletal symptoms; Complaints of chest tightness, neck stiffness, or restricted upper thoracic mobility, often associated with dysfunctional breathing patterns.
  • Ability to provide informed consent and comply with the treatment protocol.

Who cannot join

  • clinically unstable or had a neuromuscular disease, unstable cardiovascular disease, or musculoskeletal disease that may interfere with exercise
  • History of thoracic or cervical spine surgery, trauma, or fractures
  • Pregnancy or postpartum status
  • Rheumatologic diseases, a history of musculoskeletal trauma, or musculoskeletal malformations.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Chaudary Muhammad Akram Teaching Hospital, Azra Naheed Medical College, Superior University

    Lahore, Punjab Province

Other trials in Pakistan

About this study

This randomized controlled trial aims to evaluate the effectiveness of first rib mobilization and scalene muscle energy technique (MET) in improving respiratory function and reducing symptoms in patients with asthma. Asthma is a chronic inflammatory condition of the airways characterized by bronchoconstriction, airway hyperresponsiveness, and mucus overproduction, often leading to respiratory difficulty and increased use of accessory muscles such as the scalene.

Read the detailed description

Manual therapy techniques like first rib mobilization and scalene MET are believed to restore upper thoracic mobility, reduce muscle tightness, and optimize breathing mechanics. In this study, 47 asthmatic patients will be randomly assigned into two groups: Group A will receive first rib mobilization combined with respiratory physiotherapy, while Group B will receive scalene MET along with the same physiotherapy protocol. Treatment will be administered three times a week for four weeks.

Conditions
Asthma
Being tested
First Rib Mobilization + Respiratory Physiotherapy, Scalene Muscle Energy Technique (MET) + Respiratory Physiotherapy
Medical subject headings
Asthma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • First Rib Mobilization + Respiratory PhysiotherapyDiagnostic test

    Patients were given post isometric relaxation for restricted first rib in sitting position and therefore the affected elevated first rib, opposite foot of therapist was placed on the table and patient non affected arm is 'dropped' on the therapist flexed knee. The practitioner's conjointly flexes the elbow on the non-affected side placed anterior to shoulder with the hand supporting the patient facet of head. Then therapist makes contact with the tubercle of the first rib with fingers or thumb of affected side (patient) disposing of available soft tissue. slack as steady force is applied in inferior direction. The therapist eases his flexed leg and uses his supported hand to encourage patient's neck into a side flexion and rotation to affected side thus unloading the scalene tension thereon side and encourage the first rib to move anteriorly and inferiorly

  • Scalene Muscle Energy Technique (MET) + Respiratory PhysiotherapyCombination product

    MET for the scalene muscle, the participants were made to lie supine with a cushion or towel under the upper thoracic area. The PT placed his hand on the side of the participant's face/forehead to resist the isometric contraction and the other hand on the sternum. The participants were asked to perform the action of the anterior scalene muscle against PT resistance and hold it for 7-8 seconds followed by relaxation. (42) Along with the same respiratory physiotherapy protocol used in Group A. The treatment protocol was given for three sessions per week for four weeks

Study groups in NCT07036887
Study groupRoleWhat they receive
First Rib Mobilization + Respiratory PhysiotherapyExperimentalNot described
Receives: Diagnostic Test: First Rib Mobilization + Respiratory Physiotherapy
Scalene Muscle Energy Technique (MET) + Respiratory PhysiotherapyActive comparatorNot described
Receives: Combination Product: Scalene Muscle Energy Technique (MET) + Respiratory Physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. St. George's Respiratory Questionnaire (SGRQ)

    The total score has a maximum of 100 points, with values ranging from 0 to 100. The higher the number, the more impact the disease has.

    Measured: 6 Month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2025
  2. Study start4 Mar 2025
  3. Primary completion1 Jun 2025
  4. Study completion30 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
47 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07036887
Sponsor's protocol ID
DPT/Batch-Fall20/1001
Status last verified
Jun 2025
First submitted
17 Jun 2025
Last updated
25 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing First Rib Mobilization + Respiratory Physiotherapy and Scalene Muscle Energy Technique (MET) + Respiratory Physiotherapy in people with Asthma, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 25 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

St. George's Respiratory Questionnaire (SGRQ) (time frame: 6 Month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in